Source disclosure: February 13, 2026
MatsukiyoCocokara & Co. [3088.T]
TOKYO, Feb 13 (Pulse News Wire) – MatsukiyoCocokara & Co. (3088.T) reported a 7% increase in operating profit for the quarter ended December 31, 2025, compared to the same period last year.
Revenue rose to ¥839.3 billion from ¥801.5 billion. The company attributed its performance to strategic initiatives aimed at enhancing customer convenience through seamless integration of drugstore and pharmacy services, along withinvestments in digital infrastructure and expansion into key urban areas. Additionally, the acquisition of Shinsou-do Pharmacy in northern Kyushu contributed to the growth.
For the fiscal year ending March 31, 2026, MatsukiyoCocokara forecasts revenue of ¥1.10 trillion million, representing a 5% increase over the previous year. Operating profit is expected to reach ¥108.5 billion, up 6%, while net profit per share is projected at ¥89.50 billion. Despite challenges such as increased competition and geopolitical risks, the firm remains committed to its long-term strategy focusing on value creation and sustainable corporate governance.
AI-translated content. 🟢 Confidence: High See terms • Original filing